According to a new market report published by Lucintel, the future of the
viral vector & plasmid DNA manufacturing market looks promising with opportunities in antisense & RNAi, gene therapy, cell therapy, and vaccinology. The global viral vector & plasmid DNA manufacturing market is expected to grow with a CAGR of 15% from 2020 to 2025. The major drivers for this market are technological advancements to mitigate challenges posed by conventional methods of vector production, increase in the number of clinical studies, and a growing number of gene therapy cases.
To download report brochure, please go to https://www.lucintel.com/viral-vector-and-plasmid-dna-manufacturing-market.aspx and click "download brochure" tab from the menu
Viral vectors and plasmid DNA manufacturing include the use of system biology and panomics to determine the cause of a patient's illness at the molecular level, followed by use of concentrated medications to address an individual patient's illness. In this market, viral vector, plasmid DNA, and non viral vector are the major product segments. Lucintel forecasts that viral vector will remain the largest product segment over the forecast period due to necessity and applicability of this product in different research interventions.
Within this market, pharmaceutical and biotechnology companies will remain the largest end use segment over the forecast period due to continuous introduction of advanced therapies coupled with a subsequent increase in the number of gene therapy-based discovery programs by companies.
North America will remain the largest region over the forecast period due to the fact that the United States has been a major destination for all the recent advancements in the field of medicine. Increasing investments in gene therapy products in the United States have led to the growth of the market studied in recent years. In the United States, regulatory encouragement and patient advocacy have pushed rare disease clinical research to the center stage.
Kaneka Eurogentec, FinVector, Brammer Bio, Cell and Gene Therapy Catapult, FUJIFILM Diosynth Biotechnologies, Sanofi, Spark Therapeutics, Cobra Biologics, UniQure and MassBiologics are among the major suppliers in the global the viral vector & plasmid DNA manufacturing market.
Lucintel, a leading global strategic consulting and
market research firm, has analyzed growth opportunities in the global viral vector & plasmid DNA manufacturing market by product, workflow, application, end use, disease, and region. Lucintel has prepared a comprehensive research report titled “
Growth Opportunities in the Global Viral Vector & Plasmid DNA Manufacturing Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global viral vector & plasmid DNA manufacturing market by product, workflow, application, end use, disease, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
-
Viral Vector
-
Plasmid DNA
-
Non Viral Vector
By Workflow [Value ($ Million) shipment analysis for 2014 – 2025]:
-
Upstream Processing
-
Downstream Processing
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
-
Antisense & RNAi
-
Gene Therapy
-
Cell Therapy
-
Vaccinology
By End Use [Value ($ Million) shipment analysis for 2014 – 2025]:
-
Pharmaceutical and Biopharmaceutical Companies
-
Research Institutes
By Disease [Value ($ Million) shipment analysis for 2014 – 2025]:
-
Cancer
-
Genetic Disorders
-
Infectious Diseases
-
Others
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
-
United States
-
Canada
-
Mexico
-
United Kingdom
-
Spain
-
Germany
-
France
This more than 150 page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.
